Action Maia Biotechnology - MAIA

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

1,69

Prix Achat

Prix Vente

Volume échangé

112 950

1,65 Fourchette du Jour 1,765

1,27 Plage de 52 semaines 5,99

Cap du marché

42,811M

Clôture Veille

1,72

Ouverture

1,74

Dernière Transaction

3523

1.65

Dernière heure de transaction

Volume financier

US$ 190 712

VWAP

1,6885

Volume moyen (3 m)

346 814

Actions en circulation

25 332 069

Rendement du Dividende

Ratio Cours sur Bénéfices

-2,11

Bénéfice par action (BPA)

-0,78

Chiffre d'affairess

Bénéfice net

-19,77M

MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is... MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells. Show more

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

maiabiotech.com

Siège social

Wilmington, Delaware, USA

Fondé

Maia Biotechnology Inc est coté dans le secteur Pharmaceutical Preparations de la American Stock Exchange avec le ticker MAIA. Le dernier cours de clôture d'Maia Biotechnology était de US$1,72. Au cours de la dernière année, les actions de Maia Biotechnology ont été négociées dans une fourchette de prix de US$ 1,27 à US$ 5,99.

Maia Biotechnology compte actuellement 25 332 069 actions en circulation. La capitalisation boursière d'Maia Biotechnology est de US$43,57 million. Maia Biotechnology a un ratio cours/bénéfice (ratio PE) de -2.11.

Form 4 - Statement of changes in beneficial ownership of securities

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form D - Notice of Exempt Offering of Securities

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients

MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted...

MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer

Expansion study to enroll patients in the U.S. and select countries in Europe and Asia Multiple milestones attainable for 2025 MAIA...

Form 4 - Statement of changes in beneficial ownership of securities

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.26	-13.3333333333	1.95	1.95	1.5306	123217	1.73285288	CS
4	-0.32	-15.92039801	2.01	2.0898	1.5306	151266	1.85516084	CS
12	-0.35	-17.1568627451	2.04	2.63	1.5306	346814	2.07913954	CS
26	-1.48	-46.6876971609	3.17	3.742	1.5306	227287	2.28726944	CS
52	0.31	22.4637681159	1.38	5.99	1.27	267513	2.75550025	CS
156	-2.41	-58.7804878049	4.1	9.64	0.82	234370	3.20483334	CS
260	-2.41	-58.7804878049	4.1	9.64	0.82	234370	3.20483334	CS

MAIA - Frequently Asked Questions (FAQ)

What is the current Maia Biotechnology share price?

The current share price of Maia Biotechnology is US$ 1,69

How many Maia Biotechnology shares are in issue?

Maia Biotechnology has 25 332 069 shares in issue

What is the market cap of Maia Biotechnology?

The market capitalisation of Maia Biotechnology is USD 43,57M

What is the 1 year trading range for Maia Biotechnology share price?

Maia Biotechnology has traded in the range of US$ 1,27 to US$ 5,99 during the past year

What is the PE ratio of Maia Biotechnology?

The price to earnings ratio of Maia Biotechnology is -2,11

What is the reporting currency for Maia Biotechnology?

Maia Biotechnology reports financial results in USD

What is the latest annual profit for Maia Biotechnology?

The latest annual profit of Maia Biotechnology is USD -19,77M

What is the registered address of Maia Biotechnology?

The registered address for Maia Biotechnology is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19901

What is the Maia Biotechnology website address?

The website address for Maia Biotechnology is maiabiotech.com

Which industry sector does Maia Biotechnology operate in?

Maia Biotechnology operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
KNWKnow Labs Inc	US$ 2,222 (2 495,79%)	254,56k
MMAMixed Martial Arts Group Limited	US$ 0,80 (31,15%)	91,3k
SACHSachem Capital Corporation	US$ 1,33 (16,67%)	782,98k
ARMUT REX 2X Long ARM Daily Target ETF	US$ 27,08 (14,33%)	3,8k
MSTZT Rex 2X Inverse MSTR Daily Target ETF	US$ 18,47 (11,33%)	33,35M
IBOImpact Biomedical Inc	US$ 0,93 (-23,14%)	42,42k
ATCHAtlasClear Holdings Inc	US$ 1,36 (-13,92%)	802,48k
GOROGold Resource Corporation	US$ 0,5213 (-13,12%)	9,96M
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 6,0701 (-11,51%)	89,39M
LLYXDefiance Daily Target 2X Long LLY ETF	US$ 22,03 (-9,53%)	228,21k
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 20,88 (8,58%)	137,51M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 6,69 (-1,47%)	119,57M
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 6,0701 (-11,51%)	89,39M
XLFFinancial Select Sector	US$ 49,12 (-0,53%)	83,35M
SPYSPDR S&P 500	US$ 575,92 (0,56%)	78,29M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Maia Biotechnology Inc (MAIA) Cours

Maia Biotechnology Inc (MAIA)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Maia Biotechnology Inc

MAIA Dernières nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form D - Notice of Exempt Offering of Securities

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients

MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form D - Notice of Exempt Offering of Securities

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients

MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 Million

MAIA - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités